NEW YORK, Sept. 23, 2023 /PRNewswire/ — Theflow diversion aneurysm treatment market size is expected to grow by USD 2.11 billion from 2022 to 2027. In addition, the momentum of the market will be progressing at aCAGR of 8.8% during the forecast period, according to Technavio Research. The market is segmented by product (FDS and Intrasaccular flow disruption devices), end-user (Hospitals and Specialty clinics), and geography (North America, Europe, Asia, and Rest of World (ROW)). North Americais estimated to account for38%of the global market during the forecast period. A substantial portion of the global flow diversion aneurysm treatment market is represented by North America, with the US and Canada collectively holding the majority of market shares. The region’s rapid market expansion can be attributed to heightened awareness regarding aneurysm effects and treatment methodologies, a growing number of flow diversion procedures, enhanced healthcare infrastructure, and increased healthcare expenditure.This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a FREE PDF Sample Report
Acandis GmbH, BALT Group, Cardinal Health Inc., Endologix LLC, Evasc Medical Systems Corp., Imperative Care Inc., InspireMD Inc., Johnson and Johnson, Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, Merlin MD Pte. Ltd., MicroPort Scientific Corp., Oxford Endovascular Ltd., Penumbra Inc., Rapid Medical Ltd., Siemens AG, Stryker Corp., Terumo Corp., Wallby Medical LLC, and InNeuroCo
Acandis GmbH –The company offers ACCERO Stent and ACCLINO flex plus Stent for treatment of Flow Diversion Aneurysm.
To gain access to more vendor profiles available with Technavio, buy the report!
- The market share growth by theFDSsegment will be significant during the forecast period. Flow-diverting stents, commonly referred to as flow diverters, represent specialized medical devices employed in the management of specific brain vascular conditions, particularly complex and wide-necked intracranial aneurysms. These stents are designed to redirect blood flow away from the aneurysm, facilitating the formation of a blood clot within the aneurysm itself, ultimately leading to its healing and closure. Flow-diverting stents offer numerous advantages when considered as a treatment option for certain complex and wide-necked intracranial aneurysms. While not suitable for all cases, they can provide significant benefits compared to traditional treatment methods like surgical clipping when appropriately chosen and utilized. The utilization of flow-diverting stents in various applications is expected to fuel growth within this segment, consequently driving the market’s focus during the forecast period.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio
Flow Diversion Aneurysm Treatment Market: Driver & Trend:
The increasing incidence of intracranial aneurysms is a growing driver in flow diversion aneurysms.A pivotal factor propelling growth in the flow diversion aneurysm therapy market is the escalating occurrence of intracranial aneurysms. The rising prevalence of intracranial aneurysms is generating a heightened demand for efficacious and advanced treatment solutions. Flow diversion has emerged as a valuable therapeutic approach, particularly for the management of complex and sizable aneurysms that may present challenges for conventional methods. Moreover, with the global population aging, the incidence of aneurysms is expected to rise, further fueling the demand for flow diversion and other treatment alternatives. The increasing number of individuals susceptible to aneurysms is poised to stimulate the demand for flow diversion aneurysm treatment during the forecast period.
The expanding indications of flow diversion procedures are an emerging trend shaping the market growth.
Strategic alliances among market vendors are a key trend in the flow diversion aneurysm treatment market. Identify key trends, drivers, and challenges in the market.Download a FREE sample report to gain access to this information.
- How do the major trends impact the market?
- How big is the North America market?
- How do the key drivers and challenges impact the market?
The global Endovascular Abdominal Aortic Aneurysm (AAA) Repair Devices Market size is estimated to grow by USD 697.78 million at a CAGR of 5.16% between 2022 and 2027. This market research report segments the endovascular abdominal aortic aneurysm repair devices market by End-user (Hospital, ASCs, and Others), Product (Stent graft and Synthetic fabric graft), and Geography (North America, Europe, Asia, and Rest of World (ROW)). The shift towards custom-made and off-the-shelf fenestrated and branched endograft is a primary trend in the market growth.
The aneurysm coiling and embolization devices market share is expected to increase by USD 1.87 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 9.06%. This report extensively covers aneurysm coiling and embolization devices market segmentation by product (embolization coils, access and delivery services, aneurysm clips, balloon and stent-assisted coils, and flow diversion devices) and geography (North America, Europe, Asia, and Rest of World (ROW)). One of the key factors driving the global aneurysm coiling and embolization devices industry growth is the increasing prevalence of IAs and associated risks.
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by End-user
Drivers, Challenges, & Trends
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View original content to download multimedia:https://www.prnewswire.com/news-releases/flow-diversion-aneurysm-treatment-market-to-grow-by-usd-2-11-billion-from-2022-to-2027–north-america-to-account-for-38-of-market-growth—technavio-301935772.html
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.